Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases

Apoptosis is an important contributor to the pathophysiology of lung diseases such as acute lung injury (ALI) and chronic obstructive pulmonary disease (COPD). Furthermore, the cellular environment of these acute and chronic lung diseases favors the delayed clearance of apoptotic cells. This dysfunctional efferocytosis predisposes to the release of endogenous ligands from dying cells. These so-called damage-associated molecular patterns (DAMPs) play an important role in the stimulation of innate immunity as well as in the induction of adaptive immunity, potentially against autoantigens. In this review, we explore the role of apoptosis in ALI and COPD, with particular attention to the contribution of DAMP release in augmenting the inflammatory response in these disease states.

[1]  H. Iwasaka,et al.  Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. , 2011, The Journal of surgical research.

[2]  A. Coyle,et al.  Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[3]  S. Biswal,et al.  Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke – induced pulmonary injury and emphysema , 2010, Nature Medicine.

[4]  A. Coyle,et al.  HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.

[5]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[6]  Takashi Ito,et al.  Hemoperfusion with a high-mobility group box 1 adsorption column can prevent the occurrence of hepatic ischemia–reperfusion injury in rats* , 2010, Critical care medicine.

[7]  L. Zitvogel,et al.  Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. , 2010, Cancer research.

[8]  D. J. Schneider,et al.  Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[10]  Z. Prohászka,et al.  Increased circulating heat shock protein 70 levels in pregnant asthmatics , 2010, Cell Stress and Chaperones.

[11]  A. Malik,et al.  Requisite Role of the Cholinergic α7 Nicotinic Acetylcholine Receptor Pathway in Suppressing Gram-Negative Sepsis-Induced Acute Lung Inflammatory Injury , 2009, The Journal of Immunology.

[12]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[13]  R. Gallo,et al.  Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. , 2009, Molecular immunology.

[14]  M. Cohen,et al.  Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion , 2009, Critical care.

[15]  Jae Hyuk Lee,et al.  Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis , 2009, British Journal of Nutrition.

[16]  Jun Xu,et al.  Extracellular histones are major mediators of death in sepsis , 2009, Nature Medicine.

[17]  Liang Dong,et al.  Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model , 2009, Respiratory research.

[18]  G. Folkerts,et al.  ATP in the pathogenesis of lung emphysema. , 2009, European journal of pharmacology.

[19]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[20]  T. Veenstra,et al.  Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin , 2009, Nature Cell Biology.

[21]  T. Eckle,et al.  Role of extracellular adenosine in acute lung injury. , 2009, Physiology.

[22]  W. Janssen,et al.  TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[23]  L. King,et al.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. , 2009, The Journal of clinical investigation.

[24]  W. MacNee,et al.  New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. , 2009, Proceedings of the American Thoracic Society.

[25]  M. Rosengart,et al.  Low‐dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality , 2009, Journal of leukocyte biology.

[26]  J. Pfeilschifter,et al.  Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors* , 2009, The Journal of Biological Chemistry.

[27]  H. Koide,et al.  Effect of Polymyxin B-Immobilized Fiber Hemoperfusion on Serum High Mobility Group Box-1 Protein Levels and Oxidative Stress in Patients With Acute Respiratory Distress Syndrome , 2009, ASAIO journal.

[28]  J. Catravas,et al.  Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. , 2009, Biochemical pharmacology.

[29]  Russell P Bowler,et al.  Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. , 2009, American journal of respiratory and critical care medicine.

[30]  J. Tschopp,et al.  Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. , 2009, American journal of respiratory and critical care medicine.

[31]  S. Kageyama,et al.  Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. , 2009, American journal of respiratory and critical care medicine.

[32]  D. Green,et al.  Immunogenic and tolerogenic cell death , 2009, Nature Reviews Immunology.

[33]  R. Pierce,et al.  Oxidative damage to nucleic acids in severe emphysema. , 2009, Chest.

[34]  V. Nizet,et al.  Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection , 2009, Apoptosis.

[35]  A. Agustí,et al.  Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. , 2009, The Journal of clinical investigation.

[36]  Yu Cao,et al.  Protective Effect of HMGB1 A Box on Organ Injury of Acute Pancreatitis in Mice , 2009, Pancreas.

[37]  Taoyong Chen,et al.  Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway1 , 2009, The Journal of Immunology.

[38]  M. Sporn,et al.  Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice , 2009, Proceedings of the National Academy of Sciences.

[39]  Q. Gong,et al.  Protective Effect of Antagonist of High‐mobility Group Box 1 on Lipopolysaccharide‐Induced Acute Lung Injury in Mice , 2009, Scandinavian journal of immunology.

[40]  J. Kastelein,et al.  Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. , 2009, Atherosclerosis.

[41]  R. Tuder,et al.  Phagocytic clearance of apoptotic cells: role in lung disease , 2008, Expert review of respiratory medicine.

[42]  Yingkai Feng,et al.  Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury. , 2008, Experimental and molecular pathology.

[43]  C. Putterman,et al.  Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. , 2008, Immunology letters.

[44]  K. Myburgh,et al.  The Inflammatory Response to Skeletal Muscle Injury , 2008, Sports medicine.

[45]  I. Fidler,et al.  Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the Mouse , 2008, Journal of Biological Chemistry.

[46]  K. Kuwano,et al.  The role of high mobility group box1 in pulmonary fibrosis. , 2008, American journal of respiratory cell and molecular biology.

[47]  M. Crow,et al.  Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury. , 2008, Journal of applied physiology.

[48]  Y. Ling,et al.  Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats. , 2008, World journal of gastroenterology.

[49]  D. Green,et al.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. , 2008, Immunity.

[50]  M. Hasegawa,et al.  Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage. , 2008, Clinical and experimental rheumatology.

[51]  H. Iwasaka,et al.  A Neutrophil Elastase Inhibitor, Sivelestat, Reduces Lung Injury Following Endotoxin-Induced Shock in Rats by Inhibiting HMGB1 , 2008, Inflammation.

[52]  H. Iwasaka,et al.  High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis , 2008, Intensive Care Medicine.

[53]  S. Merali,et al.  Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. , 2008, American journal of respiratory cell and molecular biology.

[54]  T. Billiar,et al.  HMGB1: Endogenous Danger Signaling , 2008, Molecular medicine.

[55]  R. Forteza,et al.  Hyaluronidase expression and activity is regulated by pro-inflammatory cytokines in human airway epithelial cells. , 2008, American journal of respiratory cell and molecular biology.

[56]  H. Iwasaka,et al.  Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats , 2008, Critical care.

[57]  K. Rock,et al.  How dying cells alert the immune system to danger , 2008, Nature Reviews Immunology.

[58]  R. Tuder,et al.  Apoptosis in the lung: induction, clearance and detection. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[59]  K. Rock,et al.  The inflammatory response to cell death. , 2008, Annual review of pathology.

[60]  M. Mura,et al.  Acute lung injury and cell death: how many ways can cells die? , 2008, American journal of physiology. Lung cellular and molecular physiology.

[61]  F. Sciurba,et al.  Autoantibodies in patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[62]  T. van der Poll,et al.  PULMONARY LEVELS OF HIGH-MOBILITY GROUP BOX 1 DURING MECHANICAL VENTILATION AND VENTILATOR-ASSOCIATED PNEUMONIA , 2007, Shock.

[63]  R. Favory,et al.  ENDOTHELIAL GLYCOCALYX DAMAGE DURING ENDOTOXEMIA COINCIDES WITH MICROCIRCULATORY DYSFUNCTION AND VASCULAR OXIDATIVE STRESS , 2007, Shock.

[64]  J. Garcia,et al.  Protective effect of purinergic agonist ATPgammaS against acute lung injury. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[65]  J. Briegel,et al.  TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin , 2008, Basic Research in Cardiology.

[66]  H. Iwasaka,et al.  High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats , 2008, Intensive Care Medicine.

[67]  N. Zhong,et al.  Ethyl Pyruvate Improves Survival and Ameliorates Distant Organ Injury in Rats With Severe Acute Pancreatitis , 2007, Pancreas.

[68]  S. Chadban,et al.  TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.

[69]  S. Hodge,et al.  Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. , 2007, American journal of respiratory cell and molecular biology.

[70]  M. Matthay,et al.  Nonventilatory treatments for acute lung injury and ARDS. , 2007, Chest.

[71]  C. Lemière,et al.  Differences in proteoglycan deposition in the airways of moderate and severe asthmatics , 2006, European Respiratory Journal.

[72]  H. Iwasaka,et al.  Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. , 2007, Journal of anesthesia.

[73]  H. Wong,et al.  Heat shock response and acute lung injury. , 2007, Free radical biology & medicine.

[74]  E. Garcia-Pachon,et al.  Serum Uric Acid to Creatinine Ratio in Patients with Chronic Obstructive Pulmonary Disease , 2007, Lung.

[75]  G. Gravante,et al.  “Systemic apoptotic response” after thermal burns , 2007, Apoptosis.

[76]  Y. Takeyama,et al.  Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. , 2006, World journal of gastroenterology.

[77]  Marc Parmentier,et al.  Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. , 2006, Cytokine & growth factor reviews.

[78]  D. Pisetsky,et al.  The extracellular release of HMGB1 during apoptotic cell death. , 2006, American journal of physiology. Cell physiology.

[79]  M. Fleshner,et al.  Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[80]  W. Arap,et al.  State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. , 2006, Proceedings of the American Thoracic Society.

[81]  J. Takeda,et al.  Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. , 2006, American journal of respiratory and critical care medicine.

[82]  G. Cosgrove,et al.  State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.

[83]  I. Douglas,et al.  Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. , 2006, Chest.

[84]  D. Ren,et al.  Role of inducible nitric oxide synthase expressed by alveolar macrophages in High Mobility Group Box 1- induced acute lung injury , 2006, Inflammation Research.

[85]  I. Rahman,et al.  Oxidant and antioxidant balance in the airways and airway diseases. , 2006, European journal of pharmacology.

[86]  A. M. Houghton,et al.  Elastin fragments drive disease progression in a murine model of emphysema. , 2006, The Journal of clinical investigation.

[87]  A. Kraneveld,et al.  A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation , 2006, Nature Medicine.

[88]  J. Hogg.  Why does airway inflammation persist after the smoking stops? , 2006, Thorax.

[89]  E. Abraham,et al.  Anti-High-Mobility Group Box Chromosomal Protein 1 Antibodies Improve Survival of Rats with Sepsis , 2006, World Journal of Surgery.

[90]  G. Prestwich,et al.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.

[91]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[92]  S. Akira,et al.  Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. , 2005, The Journal of clinical investigation.

[93]  K. Tracey,et al.  Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[94]  A. Jemal,et al.  Trends in the leading causes of death in the United States, 1970-2002. , 2005, JAMA.

[95]  John D. Mitchell,et al.  Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. , 2005, American journal of respiratory and critical care medicine.

[96]  Tiejuan Mi,et al.  Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice1 , 2005, The Journal of Immunology.

[97]  K. Bai,et al.  The role of hyaluronan synthase 3 in ventilator-induced lung injury. , 2005, American journal of respiratory and critical care medicine.

[98]  R. Flavell,et al.  Role of Cathepsin S-Dependent Epithelial Cell Apoptosis in IFN-γ-Induced Alveolar Remodeling and Pulmonary Emphysema1 , 2005, The Journal of Immunology.

[99]  D. Morabito,et al.  Serum levels of Hsp60 correlate with the development of acute lung injury after trauma. , 2005, The Journal of surgical research.

[100]  J. Carcillo,et al.  Extracellular hsp70 levels in children with septic shock* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[101]  I. Douglas,et al.  HMGB1 contributes to the development of acute lung injury after hemorrhage. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[102]  I. Petrache,et al.  Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice , 2005, Nature Medicine.

[103]  N. Hagimoto,et al.  Apoptosis and epithelial injury in the lungs. , 2005, Proceedings of the American Thoracic Society.

[104]  Masaki Tanaka,et al.  Contributions of high mobility group box protein in experimental and clinical acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[105]  J. Witztum,et al.  Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory , 2004, The Journal of experimental medicine.

[106]  C. Ruppert,et al.  Alveolar antioxidant status in patients with acute respiratory distress syndrome , 2004, European Respiratory Journal.

[107]  D. Corry,et al.  An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.

[108]  John C Hall,et al.  Altered structure of autoantigens during apoptosis. , 2004, Rheumatic diseases clinics of North America.

[109]  J. Stetkiewicz,et al.  High mobility group box 1 protein as a late-acting mediator of acute lung inflammation. , 2004, International journal of occupational medicine and environmental health.

[110]  Won-Il Choi,et al.  Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. , 2004, American journal of respiratory cell and molecular biology.

[111]  Janet S. Lee,et al.  Cytokine-mediated inflammation in acute lung injury. , 2003, Cytokine & growth factor reviews.

[112]  M. Cosio,et al.  Hypothesis: Does COPD have an autoimmune component? , 2003, Thorax.

[113]  S. Hodge,et al.  Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells , 2003, Immunology and cell biology.

[114]  R. Mecham,et al.  A Site on Laminin α5, AQARSAASKVKVSMKF, Induces Inflammatory Cell Production of Matrix Metalloproteinase-9 and Chemotaxis1 , 2003, The Journal of Immunology.

[115]  X. Busquets,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[116]  N. Voelkel,et al.  Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. , 2003, American journal of respiratory cell and molecular biology.

[117]  D. Green,et al.  Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis , 2003, The Journal of cell biology.

[118]  K. Tracey,et al.  Targeting high mobility group box 1 as a late-acting mediator of inflammation. , 2003, Critical care medicine.

[119]  I. Horváth,et al.  Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma , 2002, European Respiratory Journal.

[120]  K. Tracey,et al.  HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. , 2002, Gastroenterology.

[121]  X. Busquets,et al.  Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[122]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[123]  Michael Rehli,et al.  Novel Signal Transduction Pathway Utilized by Extracellular HSP70 , 2002, The Journal of Biological Chemistry.

[124]  K. Brown,et al.  Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. , 2002, The Journal of clinical investigation.

[125]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[126]  W. MacNee,et al.  Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? , 2001, Trends in molecular medicine.

[127]  D. Palliser.  Unraveling the mechanisms by which heat shock proteins activate the immune system. , 2001, Current opinion in molecular therapeutics.

[128]  K. Tracey,et al.  Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation1 , 2000, The Journal of Immunology.

[129]  K. Kuwano,et al.  Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. , 2000, The American journal of pathology.

[130]  P. Roughley,et al.  Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. , 2000, American journal of respiratory and critical care medicine.

[131]  Stuart K. Calderwood,et al.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.

[132]  M. Gaxiola,et al.  Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.

[133]  E. Chi,et al.  Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). , 1999, Journal of immunology.

[134]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[135]  S. Shapiro,et al.  Matrix metalloproteinases. Matrix degradation and more. , 1999, American journal of respiratory cell and molecular biology.

[136]  W. MacNee,et al.  Role of oxidants/antioxidants in smoking-induced lung diseases. , 1996, Free radical biology & medicine.

[137]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[138]  A. G. Driver,et al.  Adenosine in bronchoalveolar lavage fluid in asthma. , 1993, The American review of respiratory disease.